Restoration of Function to Cvads

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2022-04-15
Clinical Trial Update: Efficacy and Safety of CUSA-081 in the Restoration of Dysfunctional Central Venous Access Device (CVAD) Functionality [Phase 3]
Phase 3 trial of CUSA-081 for restoration of dysfunctional central venous access device functionality has been withdrawn.